Aptivus (Boehringer Ingelheim Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the Aptivus drug offered from Boehringer Ingelheim Pharmaceuticals, Inc.. This HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Boehringer Ingelheim Pharmaceuticals, Inc. |
| NON-PROPRIETARY NAME: | tipranavir |
| SUBSTANCE NAME: | TIPRANAVIR |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE, LIQUID FILLED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2005-07-01 |
| END MARKETING DATE: | 0000-00-00 |
Aptivus HUMAN PRESCRIPTION DRUG Details:
| Item Description | Aptivus from Boehringer Ingelheim Pharmaceuticals, Inc. |
| LABELER NAME: | Boehringer Ingelheim Pharmaceuticals, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 250(mg/1) |
| START MARKETING DATE: | 2005-07-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0597-0003_6d6ce478-4464-9f6c-8933-8da6daee05fe |
| PRODUCT NDC: | 0597-0003 |
| APPLICATION NUMBER: | NDA021814 |
Other TIPRANAVIR Pharmaceutical Manufacturers / Labelers:
